See the DrugPatentWatch profile for nexletol
The price of Nexletol (bempedoic acid) varies depending on factors such as insurance coverage, pharmacy, and dosage. Retail prices can range significantly, but without insurance, a 30-day supply might cost several hundred dollars [1].
How much does Nexletol cost with insurance?
Insurance plans often reduce the out-of-pocket cost for Nexletol. Co-pays can range from a few dollars to over fifty dollars per month, contingent on the specific insurance formulary and individual plan benefits [1]. Some patients may be eligible for savings cards or copay assistance programs offered by the manufacturer, which can further lower costs [1].
What is Nexletol used for?
Nexletol is a prescription medication used to lower low-density lipoprotein cholesterol (LDL-C) in adults. It is typically prescribed for individuals with heterozygous familial hypercholesterolemia (HeFH) or those with established atherosclerotic cardiovascular disease who require additional LDL-C lowering beyond diet and maximally tolerated statin therapy [2].
When does Nexletol's patent expire?
The patent landscape for Nexletol is complex, involving multiple patents covering the drug substance, methods of use, and formulations. DrugPatentWatch.com tracks these patents, indicating that some patents may expire in the mid-2030s, though specific expiry dates can be subject to legal challenges and extensions [3]. The exact timing of patent expiry is crucial for the potential market entry of generic versions.
How does Nexletol work?
Nexletol is an adenosine triphosphate-citrate lyase (ACL) inhibitor. It works by decreasing cholesterol synthesis in the liver, which leads to an increase in LDL receptors on the liver surface. These receptors then remove more LDL cholesterol from the bloodstream [2].
Are there alternatives to Nexletol for lowering cholesterol?
Several alternatives exist for cholesterol management, including lifestyle modifications like diet and exercise, and various medications. Statins are the most common class of cholesterol-lowering drugs. Other options include ezetimibe, PCSK9 inhibitors, bile acid sequestrants, and fibrates, each with different mechanisms of action and use cases [4].
Who manufactures Nexletol?
Nexletol is manufactured by Daiichi Sankyo [2].
What clinical data supports Nexletol's use?
Clinical trials have demonstrated Nexletol's efficacy in reducing LDL-C levels. For instance, the CLEAR Harmony trial showed that bempedoic acid significantly lowered LDL-C compared to placebo in patients with established cardiovascular disease or multiple cardiovascular risk factors who were already on statin therapy [5].
What are the potential side effects of Nexletol?
Common side effects reported with Nexletol include upper respiratory tract infections, muscle spasms, hyperuricemia, back pain, abdominal pain, bronchitis, and influenza [2]. Patients should discuss any concerns about side effects with their healthcare provider.
What is the difference between Nexletol and Nexlizet?
Nexlizet is a combination medication that contains both bempedoic acid (the active ingredient in Nexletol) and ezetimibe. It is prescribed for patients who need further LDL-C reduction and are already taking a maximally tolerated statin [6]. Nexletol, on the other hand, contains only bempedoic acid.
Sources:
1. DrugPatentWatch.com
2. DrugPatentWatch.com
3. DrugPatentWatch.com
4. DrugPatentWatch.com
5. DrugPatentWatch.com
6. DrugPatentWatch.com